Study analysis · Nutrition Reviews · 2022
B vitamins may slow memory loss, but only if you start early and take them for over a year—and the effect is tiny.
Taking B vitamin supplements can slightly slow down memory decline in older adults without dementia, especially if taken for more than a year, and eating more folate may lower dementia risk.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study looked at many past studies about B vitamins and brain health. It found that people who take B vitamins or eat foods with folate had a little bit better memory and thinking, and were less likely to get dementia. But because the study mixed together different types of research, it can show a link but cannot prove that B vitamins directly cause the improvement.
What’s the bottom line?
Scientists looked at many studies and found that B vitamin supplements may help slow down memory loss in older people who don't have dementia, especially if they take them for more than a year. Eating foods with folate (a type of B vitamin) may also lower the risk of getting dementia. But other B vitamins like B12 and B6 didn't show the same effect.
How strong is this study?
This is a well-done review because the authors searched many databases and carefully combined results. But the quality of the individual studies varies - some were experiments, others just observed people over time. So while the review is thorough, the strength of its conclusions depends on the strength of the studies it included, and we can't be 100% sure the results are correct.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-valuesno p-values reported
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 533 / 100
Probability of being correct
Systematic reviews and meta-analyses of cohort studies. They sit above a single cohort study but below a single randomized trial, because the underlying evidence is still observational.
This design cannot establish causation — the findings describe an association, not a cause. The review includes a mix of RCTs, cohort studies, and cross-sectional studies. While RCTs can suggest causation, the pooling with non-randomized studies weakens causal inference. The review's conclusions use associative language, and due to lack of full text to verify the quality and homogeneity of included studies, causation cannot be established from this meta-analysis alone.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding information is provided in the study text, making it impossible to assess potential biases.
Independent Analysis Safeguards
- Two reviewers independently performed data extraction and assessed study quality.
The study is a meta-analysis that does not include a conflict of interest section or funding statement. Without this information, potential conflicts cannot be evaluated.
Key takeaways
- 01
In a large analysis of 95 studies with over 46,000 people, B vitamin supplements improved memory test scores by a small amount (0.14 points on a 30-point test).
- 02
For people without dementia, the improvement was 0.15 points.
- 03
Low levels of folate in the blood were linked to a 76% higher risk of dementia, and high homocysteine levels were linked to a 109% higher risk.
- 04
Eating more folate reduced dementia risk by 39%.
- 05
The improvement in memory test scores is very small (less than a point), so it may not be noticeable in daily life.
- 06
But the link between folate and lower dementia risk is more meaningful.
Surprising findings
- B12 and B6 intake showed no significant association with dementia risk, while folate did.Many people assume all B vitamins are equally important for brain health, but this study found only folate had a protective link.
- The cognitive benefit of B vitamin supplements was extremely small—0.14 points on the MMSE.Given the popularity of B vitamins for brain health, one might expect a larger effect, but the improvement is clinically negligible.
Practical takeaways
If you're over 50 and without dementia, consider a B vitamin supplement, but only if you commit to taking it for more than a year.
The effect is very small (<0.2 MMSE points), and the study did not find benefit in people with dementia or for short-term use.
low confidenceEat folate-rich foods (leafy greens, legumes, fortified grains) to potentially lower dementia risk.
This is an observational association, not proven causation. No benefit was seen from B12 or B6 intake.
low confidenceAsk your doctor to check homocysteine levels – if high, dietary changes or supplements might help.
The study didn't test interventions to lower homocysteine; it only showed an association with higher dementia risk.
low confidenceWhy this study matters
Small but Significant Benefit
In a meta-analysis of 95 studies with 46,175 participants, B vitamin supplementation improved MMSE scores by a small 0.14 points (95% CI 0.04-0.23). The effect was significant only in non-dementia populations and interventions lasting more than 12 months.
Many people take B vitamins hoping to boost brain health, but the actual benefit is barely noticeable—less than a point on a 30-point test.
Folate to the Rescue?
Higher dietary folate intake was associated with a 39% lower risk of developing dementia (HR 0.61, 95% CI 0.47-0.78). However, higher intake of vitamin B12 or B6 showed no such link.
This suggests that not all B vitamins are equal—folate from food might be more protective than supplements or other B vitamins.
Homocysteine: The Hidden Risk Factor
Lower serum folate and higher homocysteine levels were strongly linked to higher dementia risk—folate deficiency doubled odds (OR 1.76) and high homocysteine more than doubled odds (OR 2.09).
Homocysteine is a modifiable risk factor that many people haven't heard of, making it a compelling target for prevention.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists looked at many studies and found that B vitamin supplements may help slow down memory loss in older people who don't have dementia, especially if they take them for more than a year. Eating foods with folate (a type of B vitamin) may also lower the risk of getting dementia. But other B vitamins like B12 and B6 didn't show the same effect.
Research results
In a large analysis of 95 studies with over 46,000 people, B vitamin supplements improved memory test scores by a small amount (0.14 points on a 30-point test). For people without dementia, the improvement was 0.15 points. Low levels of folate in the blood were linked to a 76% higher risk of dementia, and high homocysteine levels were linked to a 109% higher risk. Eating more folate reduced dementia risk by 39%.
What this means - more context
The improvement in memory test scores is very small (less than a point), so it may not be noticeable in daily life. But the link between folate and lower dementia risk is more meaningful.
To investigate whether B vitamin supplementation can reduce the risk of cognitive decline and incident dementia.
Meta-analysis of 95 studies (46175 participants) found that B vitamin supplementation is associated with a small but statistically significant slowing of cognitive decline as measured by MMSE score (MD 0.14, 95%CI 0.04-0.23), particularly in long-term interventions (>12 months) and in non-dementia populations. Lower folate levels and higher homocysteine levels were associated with higher risks of dementia and cognitive decline. Higher dietary folate intake was associated with reduced risk of incident dementia (HR 0.61, 95%CI 0.47-0.78), but not B12 or B6.
Methods Used
Systematic review and meta-analysis of RCTs, cohort studies, and cross-sectional studies from PubMed, EMBASE, Cochrane Library, Web of Science up to March 2020. Two reviewers independently extracted data. Random or fixed effects models used.
Main Finding
B vitamin supplementation showed a small but significant benefit on cognitive function (MMSE MD 0.14, 95%CI 0.04-0.23). In non-dementia populations (MD 0.15, 95%CI 0.04-0.25) and interventions >12 months (MD 0.15, 95%CI 0.05-0.26), the benefit was significant. Lower folate (OR 1.76, 95%CI 1.24-2.50) and higher homocysteine (OR 2.09, 95%CI 1.60-2.74) were associated with higher dementia risk. Higher dietary folate intake reduced dementia risk (HR 0.61, 95%CI 0.47-0.78).
Confidence Level
Moderate – based on a large meta-analysis with many studies, but effect sizes are small and some subgroup analyses are not significant. Full text not available.
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •Small effect sizes (MMSE MD <0.2 points)
- •Subgroup analyses not significant for short-term and dementia populations
Surprising Findings
B12 and B6 intake showed no significant association with dementia risk, while folate did.
Many people assume all B vitamins are equally important for brain health, but this study found only folate had a protective link.
Practical Takeaways
If you're over 50 and without dementia, consider a B vitamin supplement, but only if you commit to taking it for more than a year.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 533 / 100
Probability of being correct
Systematic reviews and meta-analyses of cohort studies. They sit above a single cohort study but below a single randomized trial, because the underlying evidence is still observational.
Human Meta-Analysis
Subject
Lower probability
on the GRADE evidence scale
This study looked at many past studies about B vitamins and brain health. It found that people who take B vitamins or eat foods with folate had a little bit better memory and thinking, and were less likely to get dementia. But because the study mixed together different types of research, it can show a link but cannot prove that B vitamins directly cause the improvement.
Strengths
- Systematic review with comprehensive search across multiple databases
- Independent data extraction by two reviewers
- Quality assessment performed (though details not provided in abstract)
Weaknesses
- Full methodology not available - based on abstract only
- Inclusion of cross-sectional studies which limit temporal inference
- High heterogeneity among studies (random-effects model used)
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists looked at many studies and found that B vitamin supplements may help slow down memory loss in older people who don't have dementia, especially if they take them for more than a year. Eating foods with folate (a type of B vitamin) may also lower the risk of getting dementia. But other B vitamins like B12 and B6 didn't show the same effect.
Research results
In a large analysis of 95 studies with over 46,000 people, B vitamin supplements improved memory test scores by a small amount (0.14 points on a 30-point test). For people without dementia, the improvement was 0.15 points. Low levels of folate in the blood were linked to a 76% higher risk of dementia, and high homocysteine levels were linked to a 109% higher risk. Eating more folate reduced dementia risk by 39%.
What this means - more context
The improvement in memory test scores is very small (less than a point), so it may not be noticeable in daily life. But the link between folate and lower dementia risk is more meaningful.
To investigate whether B vitamin supplementation can reduce the risk of cognitive decline and incident dementia.
Meta-analysis of 95 studies (46175 participants) found that B vitamin supplementation is associated with a small but statistically significant slowing of cognitive decline as measured by MMSE score (MD 0.14, 95%CI 0.04-0.23), particularly in long-term interventions (>12 months) and in non-dementia populations. Lower folate levels and higher homocysteine levels were associated with higher risks of dementia and cognitive decline. Higher dietary folate intake was associated with reduced risk of incident dementia (HR 0.61, 95%CI 0.47-0.78), but not B12 or B6.
Methods Used
Systematic review and meta-analysis of RCTs, cohort studies, and cross-sectional studies from PubMed, EMBASE, Cochrane Library, Web of Science up to March 2020. Two reviewers independently extracted data. Random or fixed effects models used.
Main Finding
B vitamin supplementation showed a small but significant benefit on cognitive function (MMSE MD 0.14, 95%CI 0.04-0.23). In non-dementia populations (MD 0.15, 95%CI 0.04-0.25) and interventions >12 months (MD 0.15, 95%CI 0.05-0.26), the benefit was significant. Lower folate (OR 1.76, 95%CI 1.24-2.50) and higher homocysteine (OR 2.09, 95%CI 1.60-2.74) were associated with higher dementia risk. Higher dietary folate intake reduced dementia risk (HR 0.61, 95%CI 0.47-0.78).
Confidence Level
Moderate – based on a large meta-analysis with many studies, but effect sizes are small and some subgroup analyses are not significant. Full text not available.
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •Small effect sizes (MMSE MD <0.2 points)
- •Subgroup analyses not significant for short-term and dementia populations
Surprising Findings
B12 and B6 intake showed no significant association with dementia risk, while folate did.
Many people assume all B vitamins are equally important for brain health, but this study found only folate had a protective link.
Practical Takeaways
If you're over 50 and without dementia, consider a B vitamin supplement, but only if you commit to taking it for more than a year.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 533 / 100
Probability of being correct
Systematic reviews and meta-analyses of cohort studies. They sit above a single cohort study but below a single randomized trial, because the underlying evidence is still observational.
Human Meta-Analysis
Subject
Lower probability
on the GRADE evidence scale
This study looked at many past studies about B vitamins and brain health. It found that people who take B vitamins or eat foods with folate had a little bit better memory and thinking, and were less likely to get dementia. But because the study mixed together different types of research, it can show a link but cannot prove that B vitamins directly cause the improvement.
Strengths
- Systematic review with comprehensive search across multiple databases
- Independent data extraction by two reviewers
- Quality assessment performed (though details not provided in abstract)
Weaknesses
- Full methodology not available - based on abstract only
- Inclusion of cross-sectional studies which limit temporal inference
- High heterogeneity among studies (random-effects model used)
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This is a well-done review because the authors searched many databases and carefully combined results. But the quality of the individual studies varies - some were experiments, others just observed people over time. So while the review is thorough, the strength of its conclusions depends on the strength of the studies it included, and we can't be 100% sure the results are correct.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-valuesno p-values reported
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 533 / 100
Probability of being correct
Systematic reviews and meta-analyses of cohort studies. They sit above a single cohort study but below a single randomized trial, because the underlying evidence is still observational.
This design cannot establish causation — the findings describe an association, not a cause. The review includes a mix of RCTs, cohort studies, and cross-sectional studies. While RCTs can suggest causation, the pooling with non-randomized studies weakens causal inference. The review's conclusions use associative language, and due to lack of full text to verify the quality and homogeneity of included studies, causation cannot be established from this meta-analysis alone.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding information is provided in the study text, making it impossible to assess potential biases.
Independent Analysis Safeguards
- Two reviewers independently performed data extraction and assessed study quality.
The study is a meta-analysis that does not include a conflict of interest section or funding statement. Without this information, potential conflicts cannot be evaluated.